Alun McCarthy

3 years ago By Amber Wareing
  • Share on

  • Linkedin

Alun is VP Novel Target Biology & Genomics at C4X Discovery, responsible for the team that identifies new drug targets based on novel genetic insights into disease. Before joining C4X, Alun had more than 30 years experience elsewhere in the pharmaceutical industry, encompassing drug discovery & development and genetics research. In addition to experience in a large pharma company, Alun has also founded and run start-up companies, including Adorial which was acquired by C4X in 2016.

More news